STOCK TITAN

ContextLogic (NASDAQ: LOGC) director reports RSU vesting and new grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ContextLogic Holdings Inc. director Michael Farlekas updated his equity holdings through restricted stock unit (RSU) activity on January 15, 2026. An existing RSU award for 20,775 units vested and was settled into the same number of shares of Common Stock at an exercise price of $0, bringing his directly held common shares to 111,260 after the transaction. The underlying RSU position associated with that vesting was reduced to zero.

On the same date, Farlekas received a new grant of 19,206 RSUs at $0, leaving him with 19,206 derivative securities outstanding directly. Each RSU represents a contingent right to receive one share of common stock, subject to his continued service on the Board. The RSUs generally vest in full on the one-year anniversary of the grant date, may vest pro rata or be accelerated at the Board’s discretion upon termination of service, and fully vest upon a change in control or other Board-designated “special transaction,” with settlement occurring on or within 60 days after vesting unless a later date is agreed in writing.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Farlekas Michael

(Last) (First) (Middle)
2648 INTERNATIONAL BLVD STE 301

(Street)
OAKLAND CA 94601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ContextLogic Holdings Inc. [ LOGC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/15/2026 M(1) 20,775 A $0 111,260 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 01/15/2026 M(2) 20,775 (3) (3) Common Stock 20,775 $0 0 D
Restricted Stock Units $0(1) 01/15/2026 A(3) 19,206 (3) (3) Common Stock 19,206 $0 19,206 D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Common Stock, $0.0001 par value, for each RSU.
2. This reported transaction represents the settlement of RSUs vested as of January 15, 2026.
3. The RSUs were granted in connection with the Reporting Person's service as a member of the Board of Directors for the Issuer. Subject to the Reporting Person's continued service, the RSUs will vest in full on the one-year anniversary of the date of grant based upon continued service, or on a pro-rata basis upon termination of service, including resignation before vesting. Upon termination of service, the Board in its discretion may fully vest the Reporting Person's RSUs. RSUs will fully vest in connection with the occurrence of a change in control or any other transaction the Board designates as a "special transaction". Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Issuer have agreed in writing to a later settlement date pursuant to the procedures the Issuer may prescribe at its discretion).
/s/ Marianne Lewis, Attorney-in-Fact 01/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LOGC director Michael Farlekas report on January 15, 2026?

Director Michael Farlekas reported settlement of 20,775 restricted stock units (RSUs) into 20,775 shares of ContextLogic Holdings Inc. common stock at $0 per share, and a new grant of 19,206 RSUs on January 15, 2026.

How many ContextLogic (LOGC) common shares does Michael Farlekas hold after this Form 4?

Following the reported transactions, Michael Farlekas directly owns 111,260 shares of ContextLogic Holdings Inc. common stock.

How many restricted stock units does LOGC director Michael Farlekas hold after the reported transactions?

After the settlement of vested units and the new award on January 15, 2026, Michael Farlekas directly holds 19,206 restricted stock units tied to ContextLogic Holdings Inc. common stock.

What do the RSUs reported by Michael Farlekas for LOGC represent?

The restricted stock units reported by Michael Farlekas each represent a contingent right to receive one share of ContextLogic Holdings Inc. common stock with a par value of $0.0001 per share, subject to the applicable vesting conditions.

What is the vesting schedule for the LOGC RSUs granted to director Michael Farlekas?

The RSUs granted in connection with Michael Farlekas serving on the Board generally vest in full on the one-year anniversary of the grant date, based on continued service. They may vest on a pro-rata basis upon termination of service, can be fully vested at the Board’s discretion upon termination, and fully vest upon a change in control or other Board-designated “special transaction.”

When will the vested RSUs for LOGC be settled into shares for director Michael Farlekas?

Vested RSUs for Michael Farlekas will be settled into shares of ContextLogic Holdings Inc. common stock on or following the vesting date, and in any event within 60 days after vesting, unless he and the company agree in writing to a later settlement date under procedures set by the company.

Logicbio Therapeutics

OTC:LOGC

LOGC Rankings

LOGC Latest News

LOGC Latest SEC Filings

LOGC Stock Data

216.39M
27.73M
2.02%
22.65%
8.64%
Internet Retail
Retail-catalog & Mail-order Houses
Link
United States
OAKLAND